Recombinant Human LFNG Protein，His

LFNG (Lunatic fringe) is a member of the Rous-Sarcoma virus (RSV) glycoprotein family and plays a crucial role in the Notch signaling pathway, which is essential for various developmental processes and cellular differentiation. The study of LFNG has garnered attention due to its involvement in modulating cell fate decisions during embryonic development, as well as its implications in pathologies such as cancer and congenital disorders. Research indicates that LFNG acts as a glycosyltransferase that adds fucose to specific Notch ligands, altering their interaction with Notch receptors. This post-translational modification is critical for controlling signal transduction within the Notch pathway, influencing cellular behaviors like proliferation, apoptosis, and differentiation. The understanding of LFNG's function and its regulatory mechanisms provides insights into how disrupted Notch signaling contributes to diseases, making LFNG a potential therapeutic target. Recent advancements in recombinant protein production techniques have facilitated the study of LFNG, allowing researchers to investigate its structural properties, enzymatic activity, and interaction profiles in vitro and in vivo. As researchers continue to explore the multifaceted roles of LFNG in development and disease, its potential as a biomarker or therapeutic target remains a forefront area of research in molecular biology and medicinal chemistry.